Cancer Control-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2024-02-16 葵810 来自弗吉尼亚

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;临床
经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2024-01-02 ms5451321233 来自上海

审稿速度:6.0 | 投稿命中率:50.0
经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2024-01-02 ms448552511 来自上海

审稿速度:2.0 | 投稿命中率:50.0
经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-12-28 桑晒麦拉来自上海

前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-11-30 ms9000001010544398 来自福建省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：慢

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-11-21 vad392838323 来自浙江省

投稿命中率:5.0
经验分享：这是年刊，梅斯的信息不正确

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-09-05 ms6000001587552606 来自江苏省

偏重的研究方向：肿瘤
经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-02-07 ms6000000857571747 来自重庆

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2023-01-22 1465389cm38暂无昵称来自四川省

偏重的研究方向：肿瘤
经验分享：两个月，从投稿到接收

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊，发现影响因子不算高，但每年都有增长，还不错，身边也有成功发表的，准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0 经验分享：这是年刊，梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向：肿瘤 经验分享：从邀请审稿人中，直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤临床，返修三次接收，意见蛮多的，每次审稿回复约1-2个月，中途联系过编辑一次修改文件，编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]

2022-12-13 1871fae16em 来自江苏省

偏重的研究方向：肿瘤
经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久

42 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务